Wirtschaft Politik Eu Gebäude

PHT Corporation?s leadership of the international ePRO market has been demonstrated again as the company announced its service bookings were up 41% over the same 9 month period last year. PHT is the leading provider of electronic patient reported outcome (ePRO) solutions used in pharmaceutical and biotechnology clinical trials worldwide.

PHT President and CEO Phil Lee said, ?Sponsors conducting any phase of trials, ranging from small national studies to complex international ones, know they can rely on PHT?s track record for unmatched data quality and patient safety, world-class professional services and cost-efficiency.?

During this period PHT was awarded studies in a number of therapeutic areas including: CNS, cardiovascular, endocrinology, pain, respiratory, osteoarthritis, infectious disease and genitourinary. PHT was awarded an innovative new trial where blood glucose readings will be seamlessly sent to the LogPad via Bluetooth, enabling a sponsor to electronically collect glucose measurements with other patient reported data. Additionally, Jazz Pharmaceuticals recognized PHT as their key provider of ePRO solutions since 2006.

PHT?s compelling educational programs, which focus on the benefits of ePRO implementations for the clinical trials community, included two partner seminars in the third quarter of this year. PHT and Lionbridge Technologies, Inc. (NASDAQ:LIOX) sponsored a webinar to reveal the crucial elements required to avoid operational complexities and financial risk when conducting clinical trials in emerging countries. PHT and OmniComm Systems, Inc. hosted a conference for pharmaceutical and biotechnology executives. The conference speakers offered new information about the regulatory and financial implications of recent FDA actions, and an overview of how EDC and ePRO technologies shorten timelines and improve clinical trial safety.

PHT announced the promotion of long-time company executive Dwight Cooper to Vice President of Client Services. Mr. Cooper has over 15 years of experience providing leadership to software teams developing applications for the pharmaceutical industry, and 20 years of experience designing and developing commercial software applications. Cambridge Who?s Who named Lisa Markel, PHT?s Vice President of Technical Operations, as Outstanding VIP of the Year for her 35 years of achievements and leadership in the pharmaceutical industry.

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions that have been used in more than 400 clinical trials by over 100 biopharmaceutical clients. Its proven LogPad® System and versatile SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks? features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO? email alerts, and the industry?s premier study archive. Patient experiences captured firsthand by PHT?s ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review the interactive product demonstrations at PHT?s award-winning www.phtcorp.com site.

PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.